Camp4 Therapeutics (CAMP) Total Non-Current Liabilities (2023 - 2026)

Camp4 Therapeutics (CAMP) has 4 years of Total Non-Current Liabilities data on file, last reported at $74.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 565.46% year-over-year to $74.5 million; the trailing twelve-month figure through Mar 2026 stood at $74.5 million (up 565.46% YoY), and the FY2025 full-year result was $70.1 million, up 364.35% from the prior year.
• Total Non-Current Liabilities improved to $74.5 million in Q1 2026, from $70.1 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $74.5 million in Q1 2026 to a low of $11.0 million in Q3 2025.
• A 4-year average of $28.5 million and a median of $15.8 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities plunged 39.55% in 2025 and soared 565.46% in 2026, its largest moves.
• Tracing CAMP's Total Non-Current Liabilities over 4 years: stood at $16.5 million in 2023, then declined by 8.69% to $15.1 million in 2024, then soared by 364.35% to $70.1 million in 2025, then climbed by 6.35% to $74.5 million in 2026.
• Business Quant data shows CAMP's Total Non-Current Liabilities at $74.5 million in Q1 2026, $70.1 million in Q4 2025, and $11.0 million in Q3 2025.